Related Experiment Videos
[Lens epithelium necrosis factor for prevention lens opacity].
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|January 1, 1991
Summary
Lens epithelial necrosis factor (LENF) effectively eliminates lens capsule cells, preventing posterior capsule opacification after cataract surgery. This injectable solution offers a promising alternative to Nd-YAG laser treatment for this common complication.
Area of Science:
- Ophthalmology
- Cell Biology
- Biomaterials Science
Context:
- Posterior capsule opacification (PCO) is a frequent complication following cataract surgery, often necessitating Nd-YAG laser treatment.
- Current strategies aim to prevent PCO by targeting lens epithelial cells during surgery.
Purpose:
- To evaluate the efficacy of an injectable solution, lens epithelial necrosis factor (LENF), in causing irreversible damage to lens epithelial cells.
- To compare the cell-damaging effects of LENF with aqua bidestillata and a balanced salt solution control.
Summary:
- LENF demonstrated 100% irreversible damage to human epithelial carcinoma cells (HEp-2) in vitro when applied for 20 seconds or longer.
- Ex vivo testing on human capsular flaps showed LENF achieved 100% epithelial cell damage, while aqua bidestillata only achieved this in 40% of cases.
- LENF is a potent agent for preventing PCO by irreversibly destroying lens capsule epithelial cells.
Impact:
- LENF presents a novel, potentially more effective method for preventing PCO compared to existing treatments.
- Successful prevention of PCO could significantly improve long-term visual outcomes for cataract surgery patients.
- This research opens avenues for developing targeted injectable therapies in ophthalmic surgery.